In focus
Latest feed
Soulmask Unleashes Its Q2 2024 Release Window and Expansive "Shifting Sands" DLC
Turning the Page: Twist Bioscience Narrows Losses, Eyes 2026 Profitability with Renewed Vigor
Intel Realigns: $3.6 Billion Altera Divestment Fuels Strategic Focus Amidst Guidance Shift
Bill Holdings: Strong Results Mask a Lingering Growth Challenge
